Physician profile
Ryan Pitts
NPI 1346220423
$12,855.93
in general payments reported to CMS, 2019-2025
13 companies · $985 in 2025
The $985 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,983 · 2020: $310 · 2021: $2,460 · 2022: $4,980 · 2024: $138 · 2025: $985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $695 · Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $695.34 |
| Food and Beverage | $427.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $6,721.16 | 2019-2025 | |
| Pacira Pharmaceuticals Incorporated | $3,160.31 | 2022-2025 | Iovera |
| Stryker Corporation | $1,295.80 | 2019-2021 | |
| Arthrex, INC. | $1,000.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $419.42 | 2021-2025 | Gel-One Cross-Linked Hyaluronate |
| Spinesmith Holdings, LLC | $120.00 | 2019 | |
| Heron Therapeutics, INC. | $30.00 | 2021 | |
| Depuy Synthes Sales INC. | $21.83 | 2024 | Monovisc |
| Medtronic, INC. | $21.67 | 2024 | Intellis Adaptivestim |
| Amgen INC. | $20.79 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $16.88 | 2025 | |
| Baudax Bio INC. | $15.85 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Pitts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.